Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does BEVACIZUMAB Cause International normalised ratio increased? 64 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 64 reports of International normalised ratio increased have been filed in association with BEVACIZUMAB (JOBEVNE). This represents 0.1% of all adverse event reports for BEVACIZUMAB.

64
Reports of International normalised ratio increased with BEVACIZUMAB
0.1%
of all BEVACIZUMAB reports
15
Deaths
42
Hospitalizations

How Dangerous Is International normalised ratio increased From BEVACIZUMAB?

Of the 64 reports, 15 (23.4%) resulted in death, 42 (65.6%) required hospitalization, and 6 (9.4%) were considered life-threatening.

Is International normalised ratio increased Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for BEVACIZUMAB. However, 64 reports have been filed with the FAERS database.

What Other Side Effects Does BEVACIZUMAB Cause?

Off label use (12,094) Death (8,493) Diarrhoea (4,911) Disease progression (4,653) Fatigue (4,572) Nausea (4,357) Hypertension (4,309) Anaemia (3,221) Vomiting (3,193) Neutropenia (2,875)

What Other Drugs Cause International normalised ratio increased?

WARFARIN (5,622) RIVAROXABAN (863) ACETAMINOPHEN (533) ASPIRIN (448) APIXABAN (317) CLOPIDOGREL BISULFATE (314) FLUINDIONE (286) AMIODARONE (277) FUROSEMIDE (277) DABIGATRAN ETEXILATE (223)

Which BEVACIZUMAB Alternatives Have Lower International normalised ratio increased Risk?

BEVACIZUMAB vs BEVACIZUMAB-AWWB BEVACIZUMAB vs BEVACIZUMAB-BVZR BEVACIZUMAB vs BEVACIZUMAB-MALY BEVACIZUMAB vs BEXAROTENE BEVACIZUMAB vs BEYAZ

Related Pages

BEVACIZUMAB Full Profile All International normalised ratio increased Reports All Drugs Causing International normalised ratio increased BEVACIZUMAB Demographics